Skip to Content
Merck
  • Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.

Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.

The American journal of surgical pathology (2013-05-08)
Sean R Williamson, Shaobo Zhang, John N Eble, David J Grignon, Guido Martignoni, Matteo Brunelli, Mingsheng Wang, Stefano Gobbo, Lee Ann Baldridge, Liang Cheng
ABSTRACT

Clear cell papillary renal cell carcinoma (CCPRCC) shares morphologic overlap with clear cell renal cell carcinoma, although it lacks chromosome 3p and VHL gene abnormalities. Rare cases have been reported in von Hippel-Lindau (VHL) patients (germline mutation of the VHL gene), the significance of which is uncertain. We analyzed morphologic, immunohistochemical, and molecular features in 14 CCPRCC-like tumors and 13 clear cell renal cell carcinomas from 12 patients with VHL disease. Gross appearance of CCPRCC-like tumors ranged from yellow-orange to tan, red-brown, or extensively cystic. Histologic features included: small papillary tufts (79%), branched tubules (71%), branched papillae (64%), flattened peripheral cysts (64%), and apically aligned nuclei (43%). Almost all CCPRCC-like tumors (82%) lacked the characteristic immunoprofile of sporadic CCPRCC (CK7, CAIX, CD10, AMACR), often showing diffuse CD10 labeling (64%), negative or focal CK7 reactivity (55%), or both (18%). Three tumors (27%) showed strong AMACR staining. Chromosome 3p deletion was often present (82%), similar to that observed in clear cell renal cell carcinomas (80%); no CCPRCC-like tumor had chromosome 7 or 17 abnormalities. In summary, tumors that histologically resemble CCPRCC sometimes occur in patients with VHL disease but usually lack the characteristic immunohistochemical and molecular profile, suggesting that they do not share the same pathogenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Carbonic Anhydrase Isozyme II from bovine erythrocytes, lyophilized powder, ≥2,000 W-A units/mg protein
Sigma-Aldrich
Carbonic Anhydrase Isozyme II from bovine erythrocytes, Isoelectric focusing marker, pI 5.4
Sigma-Aldrich
Carbonic Anhydrase Isozyme II human, ≥80%, powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
Carbonic Anhydrase Isozyme II from bovine erythrocytes, lyophilized powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
Carbonic Anhydrase from bovine erythrocytes, ≥95% (SDS-PAGE), specific activity ≥3,500 W-A units/mg protein, lyophilized powder
Sigma-Aldrich
Carbonic Anhydrase from bovine erythrocytes, non-denaturing PAGE marker
Sigma-Aldrich
Carbonic Anhydrase from bovine erythrocytes, lyophilized powder, ≥2,000 W-A units/mg protein
Sigma-Aldrich
Carbonic Anhydrase from bovine erythrocytes, For use as a marker in SDS-PAGE
Sigma-Aldrich
Carbonic Anhydrase from bovine erythrocytes, BioReagent, suitable for GFC marker
Sigma-Aldrich
Carbonic Anhydrase I from human erythrocytes
Supelco
Carbonic Anhydrase I from human erythrocytes, Isoelectric focusing marker, pI 6.6